Drugmaker Novo Nordisk launched a new direct-to-consumer delivery platform for its GLP-1 weight loss medication Wegovy in partnership with Humana’s CenterWell pharmacy business.
Strategist | strategy-catalyst
Novo Nordisk and Eli Lilly partner with disruptors on GLP-1 D2C offerings
Relevant Roles:
Chief Strategy Officers